trimedlure: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 546164 |
| SCHEMBL ID | 434080 |
| MeSH ID | M0131594 |
| Synonym |
|---|
| tert-butyl 4-chloro-2-methylcyclohexane-1-carboxylate |
| trimedlure |
| NCGC00094562-02 |
| NCGC00094562-01 |
| 12002-53-8 |
| SCHEMBL434080 |
| cyclohexanecarboxylic acid, 4-chloro-2-methyl-, 2,2-dimethylethyl ester |
| tert-butyl 4-chloro-2-methylcyclohexanecarboxylate # |
| 7771-58-6 |
| FT-0699819 |
| t-butyl-2-methyl-4-chlorocyclohexanecarboxylate |
| tert-butyl 4-chloro-2-methylcyclohexanecarboxylate |
| DTXSID70881005 |
| tert-butyl 4-chloro-2-methylcyclohexane carboxylate |
| Q15632717 |
(-)-ceralure B1 captured consistently more male flies than trimedlure, the current male attractant used in detection programs. Compared on an equal dosage basis, Mediterranean fruit fly males were significantly more attracted to the (--ceralures B1 than to trimed lures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dose-response studies of the above compounds demonstrated that (-)-ceralure B1 and to a lesser extent, racemic ceralure B1, captured consistently more male flies than trimedlure, the current male attractant used in detection programs." | ( Field attraction of Mediterranean fruit fly, Ceratitis capitata (Wiedemann) to synthetic stereoselective enantiomers of the ceralure B1 isomer. Carvalho, LA; Jang, EB; Raw, AS, 2001) | 0.51 |
| " Compared on an equal dosage basis, Mediterranean fruit fly males were significantly more attracted to the (-)-ceralure B1 than to trimedlure in each of the sites tested except for California." | ( Improved attractants for Mediterranean fruit fly, Ceratitis capitata (Wiedemann): responses of sterile and wild flies to (-) enantiomer of ceralure B1. Carvalho, LA; Cristofaro, M; Holler, T; Jang, EB; Lux, S; Moses, AL; Raw, AS, 2003) | 0.52 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1159550 | Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening | 2015 | Nature cell biology, Nov, Volume: 17, Issue:11 | 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (37.59) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (5.88%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (94.12%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||